menu
    • menu

    Company profile for Medytox

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medytox, a global biopharmaceutical company, is at the forefront of efforts to build a better future with ceaseless R&D. Since the launch of botulinum toxin type A Meditoxin® in 2006 (trade name: Neuronox®, Siax®, Botulift®, Cunox®, Acebloc® and Meditoxin®), Medytox has shown a dramatic growth. Medytox reached nearly 40% of market share in Korea since 2009 and is expected to increase even further with various indication...
    Medytox, a global biopharmaceutical company, is at the forefront of efforts to build a better future with ceaseless R&D. Since the launch of botulinum toxin type A Meditoxin® in 2006 (trade name: Neuronox®, Siax®, Botulift®, Cunox®, Acebloc® and Meditoxin®), Medytox has shown a dramatic growth. Medytox reached nearly 40% of market share in Korea since 2009 and is expected to increase even further with various indications being included. The global botulinum toxin market continues to grow and is expected to further expand to not only medical aesthetics market but also therapeutic market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medytoxkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    626 Teheran-ro, Gangnam-gu, Seoul, (Medytox Building, Daechi-dong)
    Telephone
    Telephone
    82-2-6901-5880
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.medytox.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/medy-tox-inc.
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medytox Holds 2026 Global Anatomy Workshop in Bangkok
    Medytox Holds 2026 Global Anatomy Workshop in Bangkok

    24 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260424514357/en/Medytox-Holds-2026-Global-Anatomy-Workshop-in-Bangkok

    BUSINESSWIRE
    24 Apr 2026
    Share Share
    Medytox's BTX patent could face invalidation trial in US
    Medytox's BTX patent could face invalidation trial in US

    04 Mar 2023

    // KOREAHERALD

    https://www.koreaherald.com/view.php?ud=20230303000616

    KOREAHERALD
    04 Mar 2023
    Share Share
    AEON Confirms Strategy for ABP-450 Unaffected by Korean Court
    AEON Confirms Strategy for ABP-450 Unaffected by Korean Court

    10 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/11/2606248/0/en/AEON-Biopharma-Confirms-Development-Strategy-and-Timelines-for-ABP-450-Unaffected-by-Korean-Court-Ruling-on-Dispute-Between-Medytox-and-Daewoong-Pharmaceutical.html

    GLOBENEWSWIRE
    10 Feb 2023
    Share Share
    Medytox's Patent Suit Against Daewoong Dismissed in U.S.
    Medytox's Patent Suit Against Daewoong Dismissed in U.S.

    07 Oct 2021

    // YNA

    https://en.yna.co.kr/view/AEN20211007006700320

    YNA
    07 Oct 2021
    Share Share
    Medytox may market its BTX product through Evolus'
    Medytox may market its BTX product through Evolus'

    09 Sep 2021

    // KOREABIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=12113

    KOREABIOMED
    09 Sep 2021
    Share Share
    India needs to do more on hypertension, says Lancet global survey
    India needs to do more on hypertension, says Lancet global survey

    25 Aug 2021

    // BUSINESS STANDARD

    https://www.business-standard.com/article/health/india-needs-to-do-more-on-hypertension-says-lancet-global-survey-121082500002_1.html

    BUSINESS STANDARD
    25 Aug 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search